CMS Finalizes Reimbursement For Exact Sciences’ Colorectal Cancer Test
This article was originally published in The Gray Sheet
Executive Summary
The agency affirmed a positive payment rate for Exact Science's Cologuard DNA stool test. The firm says it is beginning to implement its marketing plan targeting docs that more frequently prescribe fecal tests, and patients more broadly on social media.